Compare Agilent Technologies Inc (A) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Agilent Technologies Inc trades at $128.67 (market cap $37.04B), while iShares 0 3 Month Treasury Bond ETF trades at $100.47. The key difference: Agilent Technologies Inc pays a 0.78% dividend while iShares 0 3 Month Treasury Bond ETF pays none. Which is the better fit depends on your goals.
| A | SGOV | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Fixed Income |
52-Week High | $157.20 | $100.74 |
52-Week Low | $110.24 | $100.28 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
SGOV, the iShares 0-3 Month Treasury Bond ETF, trades at $100.44 with no daily change, reflecting its stable, cash-equivalent nature. Technical indicators signal a bearish trend from moving averages but neutral oscillators, while support and resistance cluster tightly at $100. The ETF offers a low 0.09% expense ratio and yields around 3.54–3.65%, attracting investors seeking short-term Treasury exposure amid rate uncertainty, as highlighted in recent financial news comparing it to peers like BIL.
The outlook for SGOV remains favorable for risk-averse investors prioritizing capital preservation and modest yield, with inflows into bond ETFs surging 60% year-over-year per CNBC (2026-06-25). Key risks include potential Fed rate hikes that could pressure short-term yields and inflation concerns, though its ultra-short duration minimizes interest rate sensitivity compared to longer bonds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
